biotechnology inventions in the U.S., Europe, Japan and China. Doctrines and practice regarding patent eligibility, utility, novelty …Biotechnology has been developing at a dramatic pace. The success story of modern biotechnology industry is closely … linked with the evolution of modern patent law and patents are pillars of biotechnology industry. The context for patenting …

over patents on animals, human embryonic stem cells, human genes, and plants in the United States and Europe, she shows how …. And through these debates, the United States and Europe are developing very different approaches to patent and innovation … governance. Not just the first comprehensive look at the controversies swirling around biotechnology patents, Patent Politics is …

The increase in the number of reach-through claims filed in the field of biotechnology has been a cause for concern. In … strategies towards biotechnology reach-through claims. The report of the study concluded that the three Offices had similar … the concept underlying a reach-through claim in biotechnology. First, we conceptualise and define a reach-through claim …

enrich the conversation by sketching the situation in Europe and providing an interesting measure for comparison. In doing so … biotechnology sector, is built into the system over the years. Although the EPC was introduced as a unitary regulatory tool … law to the needs of distinct technology sectors, and in particular the biotechnology sector. Given the civil law tradition …